Table 6. MyoSets and MFM evolution at one year follow-up on dominant (D) and non-dominant (ND) sides for all SMA patients, with a cutoff at 14 years.
All patients | ≤ 14 years old | > 14 years old | ||||
---|---|---|---|---|---|---|
N | Median [Min-Max] | N | Median [Min-Max] | N | Median [Min-Max] | |
MyoGrip-ND (kg) | 18 | -0.2 [-1.9–0.4]* | 7 | 0.1 [-0.4–0.4] | 11 | -0.2 [-1.9–0.2]* |
MyoGrip-D (kg) | 17 | 0.0 [-3.6–0.6] | 6 | 0.2 [0.0–0.6]* | 11 | -0.2 [-3.6–0.3]* |
MyoPinch-ND (kg) | 19 | 0.0 [-0.4–1.3] | 7 | 0.1 [-0.2–1.3] | 12 | -0.1 [-0.4–0.1]* |
MyoPinch-D (kg) | 18 | 0.0 [-0.7–0.7] | 6 | 0.1 [-0.1–0.7] | 12 | -0.1 [-0.7–0.2] |
MoviPlate-ND (#) | 17 | -4 [-19-14] | 6 | -1 [-6-13] | 11 | -6 [-19-14] |
MoviPlate-D (#) | 18 | -1 [-22-10] | 7 | 1 [-20-10] | 11 | -2 [-22-3]* |
MFM-D2 (%) | 19 | 0.0 [-25.0–16.7] | 7 | 0.0 [-25.0–16.7] | 12 | 0.0 [-16.7–13.9] |
MFM-D3 (%) | 19 | 0.0 [-23.8–19.1] | 7 | 0.0 [-9.5–19.1] | 12 | 0.0 [-23.8–14.3] |
MFM-Total (%) | 19 | 0.0 [-12.6–11.5] | 7 | -0.3 [-12.6–8.3] | 12 | 0.0 [-11.5–11.5] |
* p-value < 0.05.